Edwards CardiobandTM Tricuspid Valve Reconstruction System Early Feasibility Study
Edwards Cardioband Tricuspid Valve Reconstruction System Early Feasibility Study
Sponsor: Edwards Lifesciences LLC
Enrolling: Male and Female Patients
IRB Number: AAAR8720
U.S. Govt. ID: NCT03382457
Contact: Kate Dalton: 347-514-3366 / keb2114@cumc.columbia.edu
Additional Study Information: The early feasibility study (EFS) of the Cardioband Tricuspid System is a prospective, single arm, multi-center study to evaluate the safety and performance of the Cardioband Tricuspid System. The Edwards Cardioband Tricuspid Valve Reconstruction System is intended for patients with tricuspid regurgitation deemed to be potential candidates for transcatheter tricuspid valve reconstruction with the Edwards Cardioband Tricuspid Valve Reconstruction System by the local Heart Team.
This study is closed
Investigator
Susheel Kodali, MD
Do You Qualify?
Are you 18 years of age or older? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder




For more information, please contact:
Kate Dalton
keb2114@cumc.columbia.edu
347-514-3366